Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
33.53
+1.27 (3.94%)
May 12, 2025, 4:00 PM - Market closed
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
$670,957
Profits / Employee
-$428,468
Market Cap
5.34B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IONS News
- 6 days ago - Ionis to host 2025 virtual Annual Meeting of Stockholders - Business Wire
- 12 days ago - Ionis Pharmaceuticals, Inc. (IONS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Ionis Pharmaceuticals Narrows Q1 Loss, Lifts Revenue Forecast While Drug Sales Surge - Benzinga
- 12 days ago - Ionis reports first quarter 2025 financial results - Business Wire
- 13 days ago - New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies - Business Wire
- 20 days ago - Ionis: Potentially A Great Time To Buy Ahead Of Q1 Earnings (Upgrade) - Seeking Alpha
- 5 weeks ago - Ionis to host expert panel discussion on sHTG - Business Wire
- 6 weeks ago - Ionis to present at upcoming investor conferences - Business Wire